Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C31H52O2 |
Molecular Weight | 456.7434 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC)[C@H](C)CCCC(C)C
InChI
InChIKey=CKDZWMVGDHGMFR-GTPODGLVSA-N
InChI=1S/C31H52O2/c1-7-9-29(32)33-24-16-18-30(5)23(20-24)12-13-25-27-15-14-26(22(4)11-8-10-21(2)3)31(27,6)19-17-28(25)30/h12,21-22,24-28H,7-11,13-20H2,1-6H3/t22-,24+,25+,26-,27+,28+,30+,31-/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0016049 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11522486 |
0.075 mM [IC50] |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
521-13-1
Created by
admin on Fri Dec 15 18:11:59 GMT 2023 , Edited by admin on Fri Dec 15 18:11:59 GMT 2023
|
PRIMARY | |||
|
C092211
Created by
admin on Fri Dec 15 18:11:59 GMT 2023 , Edited by admin on Fri Dec 15 18:11:59 GMT 2023
|
PRIMARY | |||
|
50QA4YCP7F
Created by
admin on Fri Dec 15 18:11:59 GMT 2023 , Edited by admin on Fri Dec 15 18:11:59 GMT 2023
|
PRIMARY | |||
|
208-304-7
Created by
admin on Fri Dec 15 18:11:59 GMT 2023 , Edited by admin on Fri Dec 15 18:11:59 GMT 2023
|
PRIMARY | |||
|
101741
Created by
admin on Fri Dec 15 18:11:59 GMT 2023 , Edited by admin on Fri Dec 15 18:11:59 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD